The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities
Year: 2009
Type: article
Abstract: Over the past several years, tumor necrosis factor (TNF) antagonists have become first-line agents in the treatment of moderate-to-severe psoriasis. These medications are highly effective in treating both psoriasis and psoriatic arthritis and may also reduce the risk of cardiovascular events in patients with chronic inflammatory disorders. In this article we review the use of anti-TNF therapy in psoriasis and its implications in regards to the co-morbid conditions associated with psoriasis.
Source: F1000 Medicine Reports
DOI: 10.3410/m1-30
Authors: John Yost, Johann E Gudjonsson
Institutions: University of Michigan, A. Alfred Taubman Health Care Center
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W1990950200